Early changes in soluble intracellular adhesion molecule‐1 as prognostic biomarkers to immune checkpoint inhibitor

Serologic biomarker to predict clinical outcome is needed for immune checkpoint inhibitors (ICIs). We evaluated soluble intercellular adhesion molecules‐1 (sICAM‐1) as a predictor of response to ICIs treatment. Ninety‐five patients with cancer treated with ICI were studied. The serum sICAM‐1 levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Ji, Dongmei, Jiang, Shiyu, Zhang, Qunling, Wang, Y. Ken, Zhang, Jian, Shen, Weina, Li, Wenhua, Liu, Rujiao, Wang, Jessica, Mavis, Cory, Gu, Juan J., Hu, Xichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432871/
https://www.ncbi.nlm.nih.gov/pubmed/37317057
http://dx.doi.org/10.1111/cts.13540

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10432871/
https://www.ncbi.nlm.nih.gov/pubmed/37317057
http://dx.doi.org/10.1111/cts.13540

Ejemplares similares